kupno akcji przez Sofprint Group AD - komunikat spółki SOPHARMA AD (sopharma) - komunikat ESPI

Komunikat spółki

COMMON REPORT

	POLISH FINANCIAL SUPERVISION AUTHORITY
				UNI - EN REPORT No		136	/	2025
	Date of issue:		2025-09-03
	Short name of the issuer
	SOPHARMA AD
	Subject
	Notification from "Sofprint Group" AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma
	Official market - legal basis
	Art. 56. 1. 2 of Act on Public Offering
	Unofficial market - legal basis
	Contents of the report:
	Notification from "Sofprint Group" AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma
	Annexes
	File				Description
	Sofprint_Sopharma_EN_01.09.2025.pdf				Notification from "Sofprint Group" AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD

Farmaceutyczny (far)

(short name of the issuer)

(sector according to clasification of the WSE in Warsow)

1220

Sofia

(post code)

(city)

IlienskoShosse

16

(street)

(number)

+359 2 813 42 00

+359 2 936 02 86

(phone number)

(fax)

(e-mail)

(web site)

nd

(NIP)

(REGON)

	SIGNATURE OF PERSONS REPRESENTING THE COMPANY
	Date	Name	Position / Function	Signature
	2025-09-03	Ognian Ivanov Donev	Executive Director

Nazwa jednostki:	SOPHARMA AD
Nazwa skrócona jednoskti:	SOPHARMA AD
Adres:	IlienskoShosse 16, 1220 Sofia
Telefon:	+359 2 813 42 00
Fax:	+359 2 936 02 86
NIP:	nd